欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto)	Human	lenalidomide	lenalidomide hydrochloride monohydrate	EMEA/H/C/005348	Krka, d.d., Novo mesto	2021/02/11	Authorised
Lenalidomide Krka d.d.	Human	lenalidomide	lenalidomide hydrochloride hydrate	EMEA/H/C/005729	Krka, d.d., Novo mesto	2021/02/11	Withdrawn
Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka)	Human	lenalidomide	lenalidomide hydrochloride monohydrate	EMEA/H/C/005734	Krka, d.d., Novo mesto	2021/02/11	Authorised
Lenalidomide Mylan	Human	lenalidomide	lenalidomide	EMEA/H/C/005306	Mylan Ireland Limited	2020/12/18	Authorised
Lenalidomide Accord	Human	lenalidomide	lenalidomide	EMEA/H/C/004857	Accord Healthcare S.L.U.	2018/09/20	Authorised
Revlimid	Human	lenalidomide	lenalidomide	EMEA/H/C/000717	Bristol-Myers Squibb Pharma EEIG	2007/06/14	Authorised
Lenalidomide Celgene Europe	Human	lenalidomide	lenalidomide	EMEA/H/C/000688	Celgene Europe Limited		Application withdrawn

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-